Form 4: Opus Genetics CEO Reports Stock Transaction
Insider Transaction (Form 4)
George Magrath, Chief Executive Officer and a Director of Opus Genetics, Inc., reported multiple transactions in common stock on September 9, 2026.
Summary
- Option exercise/conversion: acquired 392,157 Common Stock at $1.15 ($450,981) on September 9, 2026; holds 2,124,026 after (Direct).
- Tax/exercise-price withholding: disposed of 75,541 Common Stock at $5.97 ($450,980) on September 9, 2026; holds 2,048,485 after (Direct).
- Option exercise/conversion: disposed of 392,157 Warrant (right to buy) on September 9, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
George Magrath — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-09 | Option exercise/conversion | Common Stock | 392,157 | $1 | $451.0K | 2,124,026 |
| 2026-09-09 | Tax/exercise-price withholding | Common Stock | 75,541 | $6 | $451.0K | 2,048,485 |
| 2026-09-09 | Option exercise/conversion | Warrant (right to buy) | 392,157 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-09 | Option exercise/conversion (392,157 shares) |
| 2026-09-09 | Tax/exercise-price withholding (75,541 shares) |
| 2026-09-09 | Option exercise/conversion (392,157 shares) |
Keywords
insider transaction, Form 4, IRD, Opus Genetics, Inc., neutral, George Magrath
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.